Low Dose Naltrexone & Autoimmune Conditions
There is growing recognition in the scientific community that autoimmune diseases result from immunodeficiency, which disturbs the ability of the immune system to distinguish "self" from "non-self". The normalization of the immune system induced by LDN makes it an obvious candidate for a treatment plan in such diseases.The experience of people who have autoimmune diseases and who have begun LDN treatment has been remarkable.
- Immunosuppressive Drugs
- Ulcerative colitis
Related Conference of Low Dose Naltrexone & Autoimmune Conditions
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Low Dose Naltrexone & Autoimmune Conditions Conference Speakers
Recommended Sessions
- Autoimmune Diseases
- Cancer and Autoimmunity
- Complement in Autoimmunity
- Genetics and Epigenetics
- Infection and Autoimmunity
- Low Dose Naltrexone & Autoimmune Conditions
- Molecular Immunology
- New Cytokines and Anti-Cytokines
- Novel Therapeutic Targets
- Peptides and Autoimmune Diseases
- Prediction, Monitoring and Prevention
- Stem Cell Therapy in Autoimmune Diseases
- Therapy of Autoimmune Liver Disease
- Thyroid Autoimmunity
- Translational Immunology
Related Journals
Are you interested in
- Advances in Molecular Immunology - Allergic Conference 2024 (France)
- Allergen Identification and Characterization - Allergic Conference 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - Allergic Conference 2024 (France)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Case Studies in Allergy Diagnosis and Management - Allergic Conference 2024 (France)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials and Translational Research in Allergy and Immunology - Allergic Conference 2024 (France)
- Digital Health and Telemedicine in Allergy Care - Allergic Conference 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - Allergic Conference 2024 (France)
- Immune Responses to Vaccination - Allergic Conference 2024 (France)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics and Allergic Susceptibility - Allergic Conference 2024 (France)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunological Aspects of Drug Allergies - Allergic Conference 2024 (France)
- Immunological Basis of Food Allergy - Allergic Conference 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - Allergic Conference 2024 (France)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunomodulation in Allergy Management - Allergic Conference 2024 (France)
- Immunopathogenesis of Allergic Diseases - Allergic Conference 2024 (France)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Immunotherapy for Allergic Conditions - Allergic Conference 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - Allergic Conference 2024 (France)
- Mechanisms of Immunodeficiency Diseases - Allergic Conference 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - Allergic Conference 2024 (France)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Role of Microbiota in Allergic Disorders - Allergic Conference 2024 (France)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)